CLSTN1 and prostate cancer: Our data confirmed a switch to the onco-foetal EDB antigen in FN1. CLSTN1, which is a transmembrane and cell adhesion protein, was found to be affected by AS in colon, breast, bladder, and prostate cancer before [32,58].